http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2019003206-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e59c33cd14368512f9dfb0a821d9003e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2202-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-402
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-0023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-02
filingDate 2017-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f5a6c87fc9e22e7b176c68898ef0798
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74d8d11436d08da4c8f1ea635d4ccaae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e90ffa7749c3ff9bdb75ca689443957
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9903501d6760d2036d2bbb305d26f3d
publicationDate 2019-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2019003206-A
titleOfInvention HYALURONIC ACID GEL WITH A DIVALENT ZINC CATION.
abstract The present invention relates to a method of preparing a sterile injectable hydrogel composition, comprising the steps of: a) covalently crosslinking a glycosaminoglycan using a bi- or poly-functional crosslinking agent to form a covalently crosslinking glycosaminoglycan, b) swelling the covalently crosslinked glycosaminoglycan in a solution comprising a divalent zinc cation to form a hydrogel composition, and c) sterilizing the hydrogel composition by autoclaving to form a sterilized injectable hydrogel composition, and to sterilized injectable hydrogel compositions obtainable by said method.
priorityDate 2016-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559351
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID32051
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450770914

Total number of triples: 37.